Board of Directors


Lon R. Hays, M.D., M.B.A.


Dr. Hays graduated from medical school at the University of Kentucky in 1982 then pursued residency training at the University of Kentucky, which he completed in 1986. At that time he joined the faculty in the Department of Psychiatry. In addition to being Board Certified by the American Board of Psychiatry and Neurology, Dr. Hays also is certified by the American Society of Addiction Medicine and has Added Qualifications in both Addiction Psychiatry and Geriatric Psychiatry. He completed a Certificate of Medical Management in 1998 and went on to obtain his M.B.A. from the University Of Kentucky Gatton School Of Business in May 2001. Dr. Hays’ research interests include Opioid dependence and other aspects of addiction. Dr. Hays has served as Chairman of Psychiatry since 1998. He is the Director of Area V of the American Academy of Addiction.

Robert J. Sokol, M.D.

Immediate Past President

Dr. Sokol is Distinguished Professor of Obstetrics and Gynecology and holds the John M. Malone, Jr. M.D. Endowed Chair and Directorship of the C.S. Mott Center for Human Growth and Development and the Wayne State University School of Medicine/Detroit Medical Center, where he also served as Department Chair for six years, as well as Dean and Senior Vice President for Medical Affairs for 11 years. Among other honors, he was elected President of the Society for Maternal-Fetal Medicine, the Central Association of Obstetricians and Gynecologists, the Detroit Medical Academy and the Wayne State University Academy of Scholars. He chaired the Liaison Committee for Obstetrics and Gynecology and is Editor-in-Chief of ACOG Update, a monthly CME publication. Dr. Sokol has published extensively on the prevention of perinatal brain damage, particularly as it relates to prenatal exposure to alcohol and cocaine. His honors include many national research awards, a lifetime achievement award from the Society of Maternal-Fetal Medicine and awards from the Wayne State University School of Medicine student body, alumni and school. Dr. Sokol has authored more than 1,300 publications, including 300 referenced papers. He serves on four boards of directors of professional theaters, two of which he has chaired, is a vice chair of the board of a medical school, the American University of the Caribbean, and serves on many other boards and committees.

Martha J. Wunsch, M.D.

President – Elect

Dr. Wunsch received her M.D. degree from the Uniformed Services University School of Medicine and completed residency training in Pediatrics and a fellowship in Addiction Medicine at Virginia Commonwealth University. She currently heads an addiction clinic in Blacksburg, VA. She has served was an Associate Professor at the University of Kentucky in the Department of Behavioral Sciences and the Center on Drug and Alcohol Research. Her clinical and research interests are focused upon rural prescription drug abuse. She is a Physician Clinical Support System mentor to doctors across Appalachia providing office-based buprenorphine treatment.

James M. Vanderploeg, M.D., M.P.H.


Dr. Vanderploeg is the Director of the Clinical Preventive Medicine section in the Department of Preventive Medicine and Community Health. He serves as the Associate Director of the UTMB General Preventive Medicine residency program and is a key faculty member in the UTMB/NASA-JSC Aerospace Medicine residency program. He has an active clinical practice in performing FAA medical evaluations, primarily for pilots with medical, psychological, or substance abuse problems. He is also active in aerospace medical research as the Principal Investigator for the FAA Center of Excellence for Commercial Space Transportation at UTMB. For the past seven years he has served as the Chief Medical Officer for Virgin Galactic where he is developing the world-wide medical program for Virgin Galactic’s suborbital spaceflight. He is currently an Academician and Selector for the International Academy of Aviation and Space Medicine and is the Chair of the Fellows Group of the Aerospace Medical Association. His previous leadership activities included President of the Aerospace Medical Association, Board of Directors of the American Board of Medical Specialties, and Trustee and Executive Director of the American Board of Preventive Medicine.

Gail D’Onofrio, M.D., M.S.


Dr. D’Onofrio is Professor and Chair of the Department of Emergency Medicine, Yale University School of Medicine. In that post, she maintains an active clinical practice in addition to her teaching and research responsibilities. Dr. D’Onofrio is one of only a handful of Emergency Medicine specialists funded as a principal investigator for multiple R01 grants by the National Institutes of Health. Dr. D’Onofrio’s efforts as an educator include the development of a structured curriculum to teach Emergency Medicine specialists about screening and brief intervention (SBI) for alcohol problems. The curriculum, which employs a teaching video and skill-based practice scenarios, has been accepted by the Society of Academic Medicine and incorporated into a toolkit distributed to all emergency practitioners by the American College of Emergency Physicians. Dr. D’Onofrio also is a co-investigator on an NIH multi-center trial entitled “National Alcohol Screening Day and Academic Emergency Medicine Department Collaborative Study.” She also has helped develop the national strategic plan for training all health professionals in SBI, funded by HRSA, AMERSA, and SAMHSA. Dr. D’Onofrio is a member of the NIAAA advisory board for National Alcohol Screening Day, has received a NIDA grant for training chief residents in all disciplines, and her educational curriculum and teaching tools have been utilized throughout the United States and Canada.


Hoover Adger, Jr., M.D., M.P.H.

Dr. Adger is Professor of Pediatrics at the Johns Hopkins University School of Medicine and Director of Adolescent Medicine at the Johns Hopkins Hospital, which he joined in 1984. Since that time, he has served as Director of the Substance Abuse Assessment/Intervention Team at The Johns Hopkins Hospital Adolescent Program and as Director of The Johns Hopkins Substance Abuse Faculty Development Programs. In February 1997, Dr. Adger was selected to fill the position of Deputy Director of the White House Office of National Drug Control Policy. In July 1998, he returned to Johns Hopkins to resume his duties as a full-time faculty member. From 1999-2005, he served as Co-Director of the Strategic Planning Initiative funded by HRSA and SAMHSA/CSAT to advise the federal government and others on improving and expanding interdisciplinary education and training of health professionals in substance use disorders. He currently serves as principal investigator and project director of the HRSA-funded Leadership & Education in Adolescent Health project at the Johns Hopkins Hospital and as the faculty leader of the Florence Sabin College in the Johns Hopkins School of Medicine. Dr. Adger also is a past president of the Association for Medical Education and Research in Substance Abuse and a past president of the National Association for Children of Alcoholics.

Louis E. Baxter, M.D.

Dr. Baxter is the President and CEO of the Professional Assistance Program of New Jersey that manages impaired healthcare professionals. He is also the Medical Director for the Division of Addiction Services in the State of New Jersey Department of Human Services, and the Immediate Past-President of the American Society of Addiction Medicine. Dr. Baxter completed his undergraduate degrees in Biology and American Civilization at the University of Pennsylvania and earned his Medical Doctorate at Temple University School of Medicine. Dr. Baxter completed his Internship and residency training in Internal Medicine at UMDNJ Cooper Hospital University Medical Center. He sub-specialized in Addiction Medicine through training at Portsmouth Psychiatric Hospital. Dr. Baxter is an Associate Clinical Professor of Medicine at the University of Medicine & Dentistry New Jersey in Newark New Jersey. He is Immediate Past President of the American Society of Addiction Medicine and serves on the Board of Directors. He has also been appointed to the Board of Directors of the National Association of Drug Court Professionals. He has served on a number of National Advisory Councils and Committees which include, SAMSHA, CSAT, NIDA, and the FDA. He is a member of many other medical organizations and has many publications.

Randall Brown

Randall Brown, M.D., Ph.D.

Dr. Brown is an Associate Professor at The University of Wisconsin Department of Family Medicine and Community Health.Dr. Brown’s primary interests revolve around the treatment and prevention of substance use disorders and their complications in settings outside of the specialist treatment environment (such as primary care, hospitals, pharmacies, and criminal justice settings). He enjoys patient care, teaching, and conducting research in these areas. He is Board Certified in Family Medicine and in Addiction Medicine. After family medicine residency, Dr. Brown served as faculty at the Stanislaus County Family Practice Residency where he was also Medical Director of Stanislaus County’s methadone treatment facility. Dr. Brown came to Madison in 2001 to participate in the NIH/NRSA Primary Care Research Fellowship, with focus on addiction health services research, and he attained a PhD in UW’s Dept of Population Health Sciences in 2009. His current research includes investigations in opioid misuse prevention, mobile technology to support recovery, promotion of medication prescribing for alcohol use disorders in primary care, and potential therapeutic applications of psilocybin. He serves as a consulting physician in addiction medicine at UW Hospital (where he is the Director of the Center for Addictive Disorders), William S. Middleton Memorial Veterans Hospital, the UWHC HIV/AIDS Clinic, and at Access Community Health Centers. He is a certified prescriber of buprenorphine as adjunctive treatment for opioid dependence. Dr. Brown is also the Founding Director of the UW Addiction Medicine Fellowship Program, the Director of the UW SMPH fourth year Clinical Addiction Elective, and the Medical Director of the Overdose Prevention Program of the AIDS Resource Center of Wisconsin.

Michael M. Miller, M.D.

Dr. Miller is Associate Clinical Professor, University of Wisconsin School of Medicine and Public Health, and Medical Director, Herrington Recovery Center Rogers Memorial Hospital. He is board certified in general psychiatry and addiction psychiatry and in addiction medicine by the American Board of Addiction Medicine. He is a Fellow of the American Psychiatric Association (APA) and the American Society of Addiction Medicine (ASAM). Dr. Miller has published a number of articles, editorials, and guest commentaries, authored chapters for ASAM’s textbook, Principles of Addiction Medicine. Dr. Miller earned his MD from Tulane University Medical Center in 1979 and a BS, Psychology from Georgetown. He served as national President of the American Society of Addiction Medicine (ASAM) from 2007 through 2009. He represents the ASAM at the AMA’s Physician Consortium for Performance Improvement. Dr. Miller was elected Vice Speaker of the House of Delegates of the Wisconsin Medical Society in 2009. He holds associate clinical professorships in the Departments of Psychiatry, Family Medicine, and Internal Medicine at the University of Wisconsin School of Medicine and Public Health.

Patrick G. O’Connor, M.D., M.P.H.

Dr. O’Connor is a Professor of Medicine and Chief of the Section of General Internal Medicine at Yale University School of Medicine and Yale-New Haven Hospital in New Haven, Connecticut. Dr. O’Connor’s research and scholarly work have focused on the interface between primary care and substance abuse. He has written well over 100 papers on these topics and has been published in leading medical journals including The New England Journal of Medicine and JAMA. Dr. O’Connor’s work in the area of opiate detoxification led to research examining the efficacy of opioid maintenance therapy in treating heroin dependence in primary care settings. He and his colleagues at Yale completed a series of studies that look at the effectiveness of methadone and of buprenorphine as the pharmacological agent for this treatment in primary care settings. He has begun to examine the use of buprenorphine in patients with HIV disease. Among his accomplishments as Chief of General Internal Medicine at Yale is the recruitment of several academic “generalist” faculty to join efforts to perform research on the identification and treatment of substance use disorders in medical settings. The overall goal is to improve access for patients with substance usedisorders to high quality care for their substance use disorders in the context of their general medical care.


Jeffrey H. Samet, M.D., M.A., M.P.H.

Dr. Samet is a graduate of Brandeis University and Baylor College of Medicine. He trained in Internal Medicine at Boston City Hospital, Boston University School of Medicine (BUSM), and in a research fellowship at the Massachusetts General Hospital. He has been a primary care physician in Boston since 1983. Dr. Samet is a Professor of Medicine at Boston University School of Medicine and Professor of Social and Behavioral Sciences at the Boston University School of Public Health. In 2002, he became the Chief of General Internal Medicine at BUSM/Boston Medical Center and Vice Chair for Public Health in the Department of Medicine. Dr. Samet has a longstanding commitment to educating physicians about substance use disorders. Since 1995, he has served as Medical Director of Substance Abuse Prevention and Treatment Services for the Boston Public Health Commission. He also has been President of the Association of Medical Education and Research in Substance Abuse (1999- 2001), co-chair of the Substance Abuse Task Force of the Society of General Internal Medicine (1992-2002), and a member of the Institute of Medicine Committee on “Addressing the Quality Chasm in Mental Health and Addictive Disorders.” Dr. Samet also has chaired the ASAM Medical-Scientific Annual Conference Program Committee for the past four years.


Jeanette M. Tetrault, MD FACP FASAM

Dr. Tetrault is a graduate of Boston University School of Medicine and trained in Internal Medicine/Primary Care at Yale School of Medicine. She is currently an Associate Professor of Medicine in the Section of General Internal Medicine at Yale University School of Medicine. She is the Program Director for the Yale’s Addiction Medicine Fellowship and the co-director of the Addiction Recovery Clinic at Yale New Haven Hospital St. Rapheal’s Campus Adult Primary Care Center, which is an addiction treatment clinic and residency training site embedded within the academic primary care practice. For the past 10 years, Dr. Tetrault has served as the Internal Medicine Team Leader for the Substance Abuse and Mental Health Services Adimistration-funded Screening, Brief Intervention and Referral to Treatment (SBIRT) initiative at Yale School of Medicine. In addition to being a director for the Addiction Medicine Foundation, she is also on the Board of Directors of the Addiction Medicine Fellowship Director’s Association. She serves as co-chair of the Society of General Internal Medicine’s (SGIM) Alcohol, Tobacco and Other Drug Use Interest Group, is a past- president for the New England Region of SGIM. Dr. Tetrault was recently recognized as a Macy Foundation Faculty scholar for her work in addiction medicine curriculum development for interprofessional students. Her academic interest focuses on improving care of patients with substance use and the chronic diseases associated with addiction. Her work focuses on epidemiologic investigation, investigation of unique delivery care models, examination of safety of addiction pharmocotherapies, and addiction medicine curriculum design, evaluation, and dissemination.